Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Japan”

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid TumorsRecruiting
NCT04895709Phase 1, Phase 2Updated Aug 17, 2026
Sponsor: Bristol-Myers Squibb
Cervical Cancer · Gastric/Gastroesophageal Junction Adenocarcinoma · Microsatellite Stable Colorectal Cancer · Non-Small-Cell Lung Cancer
United States, Australia, Canada, Germany, Israel +3 more
A Study to Learn About Study Medicine Called PF-08049820 in People With EczemaRecruiting
NCT07216027Phase 2Updated Aug 17, 2026
Sponsor: Pfizer
Atopic Dermatitis · Eczema, Atopic
United States, Canada, China, Japan
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal CancerRecruiting
NCT07221357Phase 2, Phase 3Updated Aug 17, 2026
Sponsor: Bristol-Myers Squibb
Untreated, Unresectable, or Metastatic Colorectal Cancer
United States, Argentina, Australia, Austria, Belgium +21 more
A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy（REACH-DMD）Completed
NCT04587908Phase 3Updated Aug 17, 2026
Sponsor: Taiho Pharmaceutical Co., Ltd.
Duchenne Muscular Dystrophy
Japan
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial CancerNot Yet Recruiting
NCT07578649Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Endometrial Neoplasms · Endometrial Cancer
Japan
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive PatientsActive Not Recruiting
NCT06857955Phase 2Updated Aug 17, 2026
Sponsor: Novartis Pharmaceuticals
Hypertension
United States, Japan, Singapore
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung CancerRecruiting
NCT07226999Phase 2, Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Small Cell Lung Cancer (SCLC)
United States, Australia, China, France, Germany +5 more
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)Active Not Recruiting
NCT04862663Phase 3Updated Aug 17, 2026
Sponsor: AstraZeneca
Locally Advanced (Inoperable) or Metastatic Breast Cancer
United States, Argentina, Australia, Belgium, Brazil +18 more
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)Recruiting
NCT05254743Phase 3Updated Aug 17, 2026
Sponsor: Loxo Oncology, Inc.
Chronic Lymphocytic Leukemia · Leukemia, Lymphocytic · Leukemia, B-cell · Small Lymphocytic Lymphoma
United States, Argentina, Australia, Austria, Belgium +18 more
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaRecruiting
NCT06023589Phase 3Updated Aug 17, 2026
Sponsor: AstraZeneca
Asthma
United States, Argentina, Brazil, Canada, China +17 more
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)Recruiting
NCT07144280Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Non-small Cell Carcinoma · Non-Small Cell Lung Cancer Metastatic · Non-Small Cell Lung Carcinoma
United States, Argentina, Australia, Belgium, Brazil +24 more
A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)Active Not Recruiting
NCT04546009Phase 3Updated Aug 17, 2026
Sponsor: Hoffmann-La Roche
Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
United States, Argentina, Australia, Austria, Belgium +25 more
A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 YearsActive Not Recruiting
NCT07596173Phase 3Updated Aug 17, 2026
Sponsor: GlaxoSmithKline
Diphtheria-Tetanus-acellular Pertussis Vaccines
Japan
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCActive Not Recruiting
NCT04821622Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Prostate Cancer
United States, Argentina, Australia, Belgium, Bulgaria +22 more
Specified Drug-use Surveillance of Fabhalta CapsulesActive Not Recruiting
NCT06606314N/AUpdated Aug 17, 2026
Sponsor: Novartis Pharmaceuticals
Paroxysmal Nocturnal Hemoglobinuria
Japan
A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)Active Not Recruiting
NCT04895696Phase 2Updated Aug 17, 2026
Sponsor: Beeline Medicines Corporation
Systemic Lupus Erythematosus
United States, Argentina, Australia, Brazil, Chile +14 more
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.Recruiting
NCT07227012Phase 1, Phase 2Updated Aug 17, 2026
Sponsor: Pfizer
Carcinoma, Hepatocellular · Hepatocellular Cancer · Hepatocellular Carcinoma · Unresectable Hepatocellular Carcinoma
United States, Japan, Puerto Rico, Taiwan
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe EczemaRecruiting
NCT06807268Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Eczema
United States, China, Germany, Hungary, Japan +3 more
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their BladderRecruiting
NCT07475806Phase 2Updated Aug 17, 2026
Sponsor: Astellas Pharma Global Development, Inc.
Muscle-invasive Bladder Cancer
United States, Germany, Japan, South Korea, Spain +1 more
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid TumorsRecruiting
NCT07360314Phase 1Updated Aug 17, 2026
Sponsor: EMD Serono Research & Development Institute, Inc.
Advanced Solid Tumors
United States, Canada, Japan, Spain
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal CancerRecruiting
NCT07392892Phase 2, Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma · Metastatic Gastric Cancer · Gastroesophageal Junction Cancer · Esophageal Adenocarcinoma
United States, China, Israel, Italy, Japan +3 more
A Phase 3 Study of Fenfluramine Hydrochloride in Rett SyndromeRecruiting
NCT07503444Phase 3Updated Aug 17, 2026
Sponsor: UCB BIOSCIENCES, Inc.
Rett Syndrome
United States, Belgium, France, Hungary, Italy +3 more
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial CancerRecruiting
NCT07166094Phase 3Updated Aug 17, 2026
Sponsor: Genmab
Endometrial Cancer · Recurrent or Progressive Endometrial Cancer
United States, Australia, Belgium, Brazil, Canada +14 more
Breakthrough Platform Trial for PCASNot Yet Recruiting
NCT07769086NAUpdated Aug 17, 2026
Sponsor: Kagawa University
Cardiac Arrest (CA) · Post Cardiac Arrest Syndrome
Japan
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric ParticipantsRecruiting
NCT05835310Phase 3Updated Aug 14, 2026
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
United States, Argentina, Brazil, Canada, China +12 more

Previous page Next page